awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q52581752-A7CE19B6-3246-443D-A0A7-67FF3BE8CCB5
Q52581752-A7CE19B6-3246-443D-A0A7-67FF3BE8CCB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52581752-A7CE19B6-3246-443D-A0A7-67FF3BE8CCB5
Current therapeutic landscape for advanced gastroesophageal cancers.
P2860
Q52581752-A7CE19B6-3246-443D-A0A7-67FF3BE8CCB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52581752-A7CE19B6-3246-443D-A0A7-67FF3BE8CCB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2cb2430762bfd4e371435f43b09963a1a886457e
P2860
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction